Mathé G - Search Results

1

Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.

Kim-Triana B, Misset JL, Madelmont JC, Godenèche D, Musset M, Mathé G. Kim-Triana B, et al. Among authors: mathe g. Anticancer Drugs. 1992 Jun;3(3):225-31. doi: 10.1097/00001813-199206000-00004. Anticancer Drugs. 1992. PMID: 1525402

2

Phase I trial of cystemustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.

Mathé G, Misset JL, Triana BK, Godenèche D, Madelmont JC, Meyniel G. Mathé G, et al. Drugs Exp Clin Res. 1992;18(4):155-8. Drugs Exp Clin Res. 1992. PMID: 1451646 Clinical Trial.

3

Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisone.

Blazsek I, Musset M, Boulé D, Labat ML, Bringuier MF, Comisso M, Le Maignan C, Ribaud P, Mathé G, Misset JL. Blazsek I, et al. Among authors: mathe g. Cancer Detect Prev. 1992;16(4):259-64. Cancer Detect Prev. 1992. PMID: 1458517

4

Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemia.

Blazsek I, Farabos C, Musset M, Goldschmidt E, Comisso M, Benavides M, Wang ZY, Labat ML, Mathé G, Misset JL. Blazsek I, et al. Among authors: mathe g. Biomed Pharmacother. 1991;45(4-5):169-77. doi: 10.1016/0753-3322(91)90104-2. Biomed Pharmacother. 1991. PMID: 1932600

5

Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity.

Lévi F, Benavides M, Chevelle C, Le Saunier F, Bailleul F, Misset JL, Regensberg C, Vannetzel JM, Reinberg A, Mathé G. Lévi F, et al. Among authors: mathe g. J Clin Oncol. 1990 Apr;8(4):705-14. doi: 10.1200/JCO.1990.8.4.705. J Clin Oncol. 1990. PMID: 2179481 Clinical Trial.

6

Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum.

Mathé G, Kidani Y, Segiguchi M, Eriguchi M, Fredj G, Peytavin G, Misset JL, Brienza S, de Vassals F, Chenu E, et al. Mathé G, et al. Biomed Pharmacother. 1989;43(4):237-50. doi: 10.1016/0753-3322(89)90003-6. Biomed Pharmacother. 1989. PMID: 2675999

7

An oriented phase II trial of THP-adriamycin in breast carcinoma.

Mathé G, Umezawa H, Oka S, Misset JL, Brienza S, de Vassal F, Musset M, Ribaud P, Tapiero H. Mathé G, et al. Biomed Pharmacother. 1986;40(10):376-9. Biomed Pharmacother. 1986. PMID: 3580506

8

Qualitative and quantitative analysis of a new sulphur-containing nitrosourea in blood by high-performance liquid chromatography.

Labarre P, Godeneche D, Madelmont JC, Triana K, Mathe G, Veyre A. Labarre P, et al. Among authors: mathe g. J Chromatogr. 1987 Aug 7;419:381-7. doi: 10.1016/0378-4347(87)80304-3. J Chromatogr. 1987. PMID: 3667796 No abstract available.

9

Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rate.

Misset JL, Metz R, Gil-Delgado M, Keiling R, Cappelaere P, Armand JP, Prévot G, Grimbert J, Mathé G, Hibberd M, et al. Misset JL, et al. Among authors: mathe g. Anticancer Res. 1987 Jul-Aug;7(4B):737-40. Anticancer Res. 1987. PMID: 3674760

10

Cytostatic action of two nitrosoureas derived from cysteamine.

Bourut C, Chenu E, Godenèche D, Madelmont JC, Maral R, Mathé G, Meyniel G. Bourut C, et al. Among authors: mathe g. Br J Pharmacol. 1986 Nov;89(3):539-46. doi: 10.1111/j.1476-5381.1986.tb11154.x. Br J Pharmacol. 1986. PMID: 3801787 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,044 results

Search Page

Filters